In case you missed it, there is a lawsuit against the Department of Justice, the Drug Enforcement Agency, and Attorney General Jeff Sessions – the text of which reveals the history of the 12,000-year relationship between humans and cannabis and how prohibition not only negatively affects the plaintiffs but potentially all humankind.

The suit is filed in the Southern District U.S. Court in New York on behalf of former NFL player Marvin Washington; disabled U.S. Military veteran Dean Bortell and his daughter Alexis, now 12-years-old, who suffers from intractable epilepsy; Sebastien Cotte, father of Jagger, a now 7-year-old boy suffering from Leigh’s Disease; Jose Belen, a 70 percent disabled Operation Iraqi Freedom veteran; and the Cannabis Cultural Association.

The Plaintiffs

Alexis, who resides with her family in Colorado as a “medical refugee,” is originally from Texas. She has received the most national attention for her role in the suit, catching headlines like “12-Year-Old Sues Attorney General Jeff Sessions to Legalize Medical Marijuana.” She’s also written a book called “Let’s Talk About Medical Cannabis: One of the Earliest Medical Communities Seen Through the Eyes of its Youngest Advocate.” Her father, Dean, is a 100 percent disabled Navy veteran.

Washington, another resident of Texas who in 1999 won a Super Bowl with the Denver Broncos, currently works with Swiss firm Isidiol that manufactures CBD products. According to the suit, Washington eyes expanding his business to include whole-plant cannabis products – and would like to receive federal funding through the Minority Business Enterprise Program to expand his business but is unable to do so due to cannabis’ Schedule I federal status.

Belen, 35 and from Florida, is an Operation Iraqi Freedom veteran who is diagnosed with post-traumatic stress disorder. According to the complaint, Belen is “unable to forget and/or otherwise cope with his memory of the horrors of war that he had witnessed in Iraq.”

Jagger, who lives in Georgia with the family, might not be alive if not for cannabis. Leigh’s Disease kills “approximately 95 percent of people afflicted with it” if diagnosed before age two by the time they are 4-years-old, the suit says. Jagger was diagnosed at age one. He is now seven.

The Cannabis Cultural Association is a New York-based non-profit which helps “marginalized communities engage in the legal cannabis industry, emphasizing criminal justice reform, access to medical cannabis, and adult use legalization.”

The Defendants

Jeffrey Beauregard Sessions III, former Alabama Senator and Attorney General of the United States since 2017. Sessions might be most infamous to the cannabis community for saying that “good people don’t smoke marijuana” and for rescinding federal protections for state-legal cannabis programs outlined in the Cole Memo.

The U.S. Department of Justice, the federal agency headed by Sessions responsible for enforcing U.S. law, including the crimes violating the Controlled Substances Act. Under the Barack Obama Administration, the Justice Department had taken a hands-off approach to state-approved cannabis programs with a directive known as the Cole Memo. Sessions rescinded that memo in January.

Charles “Chuck” Rosenberg and the Drug Enforcement Agency. The lawsuit contends that the DEAs “legal mechanism available to the public to file petitions to change the classifications of drugs and medications previously scheduled under the auspices of the CSA is illusory.”

The suit points to eight such attempts by governors, individuals, and organizations to de-schedule or reschedule cannabis under the CSA that were either denied or declined by the DEA. One, by the Hemp Industries Association and the Kentucky Hemp Industry Council, filed last June is still pending. However, in 1999 – after four years of consideration – the agency granted a request by UNIMED Pharmaceuticals Inc, manufacturers of Marinol, to reclassify the drug from Schedule II to Schedule III. Marinol, a synthetic cannabinoid, was approved by the Food and Drug Administration in 1985 to “treat nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional treatments” and to “treat appetite loss associated with weight loss in AIDS patients.”

Rosenberg once quipped that medical cannabis is “a joke.”

Under the glow of LED grow lights inside of a Washington cannabis cultivation center. Photo credit: Sarah Climaco

(Some of) the Claims

The lawsuit contends that the placement of cannabis on the federal drug schedule is unconstitutional, violating due process protections of the Fifth Amendment of the Constitution. The federal government, it says, “does not believe, and upon information and belief never has believed” cannabis meets the requirements for a Schedule I designation under the CSA.

“Indeed, the Federal Government has admitted repeatedly in writing, and implemented national policy reflecting, that cannabis does (sic), in fact, have medical uses and can be used and tested safely under medical supervision. On that basis, the Federal Government has exploited Cannabis economically for more than a decade by securing a medical cannabis patent and entering into license agreements with medical licensees,” the suit says.

It points out that the government has had a federal program since the 1970s which supplies patients with medical cannabis.

“The notion that the Federal Government genuinely believes that cannabis has no medical application and is so dangerous that, as with heroin, it cannot be tested even under strict medical supervision, is so absurd that it must be rejected as a matter of law. The Federal Government does not believe in the factual prerequisites underlying its own statute,” the lawsuit contends.

Secondly, the lawsuit argues that the federal Schedule I classification was implemented during the Nixon Administration’s “war” on African-Americans and “anti-war hippies” as a means to arrest and jail leaders of those communities.

The lawsuit claims that prohibition violates citizens’ right to travel due to the current state-by-state patchwork of laws and that the federal government’s cannabis classification violates the Tenth Amendment of the Constitution because the government is regulating intra-state commerce.

“While empowered by Article I to regulate interstate and international commerce, Congress does not have the authority to regulate purely intra-state activities which do not have any impact on the national economy,” the suit states. “Any use of medical Cannabis that is legalized and regulated entirely within an individual State’s borders does not have any appreciable impact on the national economy. And Congress, in enacting the CSA, never believed that the cultivation, distribution and sale of Cannabis, purely at the intra-state level, ever affected or will affect the national economy.”

The Government response

Obviously, the government is seeking to have the case tossed, arguing, primarily, that the “plaintiffs failed to exhaust an available administrative remedy – the statutory rescheduling process – before bringing the lawsuit,” and that previous cases have already rejected the lawsuit’s premises.

“There is no fundamental right to use marijuana, for medical purposes or otherwise,” the government’s Motion to Dismiss states. “Because such a right is not ‘implicit in the concept of ordered liberty’ or ‘deeply rooted in this Nation’s history,’ the Court should reject such a claim.”

The plaintiffs’ attorneys contend that the government’s response is “a regurgitation of prior claims, made by different litigants, who relied upon arguments and claims” their clients “do not make, under different circumstances, in many instances more than 20 years ago.”

“There is a substantive due-process violation because the government can’t possibly believe that cannabis should be Schedule I.”

Joseph Bondy, a CCA executive board member and life member of the National Organization for the Reform of Marijuana Laws’ National Legal Committee, is one of the attorneys fighting the government on behalf of the plaintiffs. The CCA is pursuing the claim that cannabis’ Schedule I status violates the Equal Protection Clause of the Constitution because the laws “are grounded in discrimination and applied in a discriminatory fashion,” Bondy said in an interview with Ganjapreneur.

“These laws continue to impact communities of color disparately and unfairly,” Bondy explained. “The proof is in the pudding, so to speak.”

Among those testifying on behalf of the plaintiffs is Roger Stone – a member of the Nixon Administration who can speak directly to Nixon’s former White House Counsel and Chief Domestic Policy Advisor John Ehrlichman’s bigoted reasoning for ensuring cannabis was, not only scheduled under the CSA, but branded “highly addictive” with “no medical use.”

Bondy said that the allegations raised in the complaint “have to be presumed as true” and that government lawyers are arguing that the team has “failed to state claims upon which relief can be granted.”

“We feel strongly we are going to win,” he said, conceding that while other cases challenging cannabis’ scheduling have been ruled in the government’s favor, this case challenges different facts and several factors add to the case’s strengths — public opinion, research, and “legislative opinion as far down the road on legalization” as it is now.

“If we win the claim that the controlled substances act is unconstitutional as it pertains to marijuana it means that marijuana would be de-scheduled,” Bondy stated, matter-of-factly, “until such time as there is some further Congressional enactment.”

The reality is, Bondy admits, that if the case survives this lower court – and the government’s motion to dismiss – the government will, of course, appeal the ruling and whoever loses that case would appeal that ruling to the U.S. Supreme Court. All of this could take years, but Bondy suggested that during that time Congress could take action on cannabis’ status, rendering the whole suit “moot.”

“We don’t care how we get to legalization – the fastest course is the best course – but this seems to be a track that is moving forward at a pretty rapid pace,” he explained, noting that the judge granted oral arguments the day after Sessions rescinded the Cole Memo.

Inside of an indoor, medical cannabis grow operation. Photo credit: Sarah Climaco

Unfortunately, Bondy explained, if the lawsuit were successful and cannabis was indeed de-scheduled, it would not release individuals being held on federal and state cannabis crimes but they would have standing to seek to have the convictions vacated and be released from jail under a “writ of habeas corpus.”

Bondy says the government “can’t have it both ways” – they cannot hold a patent for cannabis as a neuroprotectant, they cannot give patients medical cannabis, and cannot issue federal memos choosing not to crack down on violations of federal law while maintaining that cannabis “has no medical value” and “a high potential for abuse.”

“The notion that marijuana should remain a Schedule I is absolutely foolish,” Bondy said. “No one believes it. The Surgeon General doesn’t believe it, half of Congress doesn’t believe it, politicians don’t believe it, Jeff Sessions probably doesn’t even believe it.”

Oral arguments to determine whether the case will be thrown out are set for Wednesday.

Do you own a cannabis industry business? Create a listing in our directory and get discovered by new clients - Click Here

Tags: , , , , | Categories: Cannabis Politics Medical Marijuana News

Learn about cannabis businesses:

View the directory | Get featured here

  • MJ Freeway

    MJ Freeway® is the industry-leading software, consulting, and data solution for cannabis businesses, processing $5B in cannabis sales transactions and serving clients in every regulated market in the United States, Canada, Europe, and Australia. Founded in 2010 and designed and built specifically for cannabis businesses, MJ Freeway's technology includes a patented seed to sale supply chain ERP Platform which leverages sophisticated business intelligence insights.

  • 4blooms

    4blooms is San Diego’s first marijuana-specific marketing agency. The agency works with businesses involved in all aspects of the cannabis industry across the U.S., from growers to dispensaries to smoke shops. The team’s deep experience in web development, design and marketing makes 4blooms able to handle all aspects of business operations.

  • Smokin’ Hot Solutions

    Smokin’ Hot Solutions was started seven years ago by three entrepreneurs from Philadelphia. From various entrepreneurial backgrounds, we came together with one cohesive goal; to build a cannabis marketing agency with an innovative and thoughtful approach. At a time when there were few specialty cannabis marketing agencies, and few willing to take the risk, we seized the opportunity. We cemented ourselves as the go-to agency for digital marketing in the cannabis industry.

  • My Cannabis Accountant

    We are a Boutique Accounting firm focused on the cannabis industry. Our management team has over 100 years of combined experience in public accounting. Running a legal cannabis-based business can be complicated. Let us make sure your business is compliant with all federal, state and local financial regulations so that you can focus on your business.

  • Mac & Fulton Talent Partners

    Mac & Fulton Talent Partners is the premier recruiting agency for the indoor gardening and cannabis industries. For our client companies and candidates, M&F takes on the role of trusted partner and advisor in the development of long-term relationships. To this end, M&F's approach to recruiting and staffing in the cannabis space is founded on the understanding that our success is always determined by yours.

  • California Cannabis CPA

    California Cannabis CPA is the premiere CPA firm that helps individuals and companies working in the Cannabis Industry with all tax planning, compliance, preparation, savings, and peace of mind.

  • GRND: Global Recruiting Network Development

    GRND is a global recruiting agency that specializes in executive recruiting. GRND recruits and retains elite professionals that bring leadership, ethics, professionalism, and innovation to the cannabis industry. At GRND, we’ve created a culture of community that stretches across continents. We value our candidates and clients by bringing value to their lives and businesses. When we work together, we grow together. Ready To Grow?

  • Accounting For Cannabis

    Accounting for Cannabis proudly assists clients with Marijuana-based businesses to stay compliant with complex cannabis-based accounting regulations. Accounting for Cannabis utilizes technology that not only helps our clients comply with local and federal rules and regulations but also gives them the freedom to do the work they love. We specialize in IRC 280e as well as Cash Management and Internal Control.


    Ganjapreneur is a news and networking resource for cannabis professionals. Our ultimate mission is to help the cannabis industry grow, by advancing the cause of cannabis normalization through responsible business.

  • Sapphire Risk Advisory Group

    Sapphire is an organization of professionals whose careers are centered on the science of preventing crime and increasing pro-business results through the implementation of controls and processes. Our vision is to create environments that are crime adverse due to strategic planning and foresight. Sapphire will be in your corner with advice and counsel as long as your organization is continuing to grow.

  • Ganja Law, PLLC

    Ganja Law, PLLC is the industry's one-stop legal expert, defense, and a leading source of knowledge. Our firm will handle your legal and/or business issues from seed to sale and all points in between. Should the issue be licensing, compliance, MED consulting, criminal defense, investment related, or industry related such as cannabis business law and specialized contracts, we will get the job done.

  • Precision Extraction Solutions

    Precision® Extraction Solutions is the industry leader in cannabis extraction equipment, training and consulting. Precision® extraction systems are world renowned for quality, safety and precise operation. Costing half of comparable CO2 systems, with nine times more efficient processing, more award winning concentrates are made with Precision® than any other brand.

Looking for a career in the cannabis industry?

Upload your resume and get discovered by industry recruiters for only $1/month

Post Your Resume View all jobs

Recent Job Postings

Additional resources:

Cannabis Books

Learn about the endocannabinoid system & more!

Cannabis Stocks

Find publicly-traded cannabis & hemp companies

Medical Research

Explore our library of medical cannabis studies

Subscribe for daily cannabis news, announcements, and business insights.

Stay informed about the latest cannabis industry news, policy progress, and business developments.